Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis

Counterterrorism: creating a safe, stable, easily stored anthrax vaccine A vaccine candidate for anthrax infection shows promise for improving preparedness for a biological attack. Bacillus anthracis, the bacterium responsible for anthrax is a top-tier bioterrorism agent due to its high lethality an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: B. Kim Lee Sim, Minglin Li, Manuel Osorio, Yun Wu, Tint T. Wai, Johnny W. Peterson, Eric R. James, Sumana Chakravarty, Lixin Gao, Rui Xu, Natasha KC, Richard E. Stafford, William S. Lawrence, Linsey A. Yeager, Jennifer E. Peel, Satheesh K. Sivasubramani, Ashok K. Chopra, Svetlana Filippova, Stephen L. Hoffman
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Acceso en línea:https://doaj.org/article/e6ed55cb74e9406db34a5f3fb0bf3838
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e6ed55cb74e9406db34a5f3fb0bf3838
record_format dspace
spelling oai:doaj.org-article:e6ed55cb74e9406db34a5f3fb0bf38382021-12-02T16:20:00ZProtection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis10.1038/s41541-017-0018-42059-0105https://doaj.org/article/e6ed55cb74e9406db34a5f3fb0bf38382017-06-01T00:00:00Zhttps://doi.org/10.1038/s41541-017-0018-4https://doaj.org/toc/2059-0105Counterterrorism: creating a safe, stable, easily stored anthrax vaccine A vaccine candidate for anthrax infection shows promise for improving preparedness for a biological attack. Bacillus anthracis, the bacterium responsible for anthrax is a top-tier bioterrorism agent due to its high lethality and spore stability. The current FDA-approved anthrax vaccine and other vaccine candidates in development lack ease of preparation, have short shelf lives and adverse effects. B. Kim Lee Sim of Protein Potential LLC and her collaborators combined key B. anthracis genetic material into an existing typhoid vaccine. The vaccine vector possesses high stability, a strong safety record, and offers long-term protection after oral administration, which Sim’s group hopes to preserve in their candidate anthrax vaccine. The team showed that their hybrid vaccine conferred excellent protection in rabbits and a short vaccination regimen, and suggest further studies into its suitability for human vaccine studies.B. Kim Lee SimMinglin LiManuel OsorioYun WuTint T. WaiJohnny W. PetersonEric R. JamesSumana ChakravartyLixin GaoRui XuNatasha KCRichard E. StaffordWilliam S. LawrenceLinsey A. YeagerJennifer E. PeelSatheesh K. SivasubramaniAshok K. ChopraSvetlana FilippovaStephen L. HoffmanNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 2, Iss 1, Pp 1-7 (2017)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
B. Kim Lee Sim
Minglin Li
Manuel Osorio
Yun Wu
Tint T. Wai
Johnny W. Peterson
Eric R. James
Sumana Chakravarty
Lixin Gao
Rui Xu
Natasha KC
Richard E. Stafford
William S. Lawrence
Linsey A. Yeager
Jennifer E. Peel
Satheesh K. Sivasubramani
Ashok K. Chopra
Svetlana Filippova
Stephen L. Hoffman
Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis
description Counterterrorism: creating a safe, stable, easily stored anthrax vaccine A vaccine candidate for anthrax infection shows promise for improving preparedness for a biological attack. Bacillus anthracis, the bacterium responsible for anthrax is a top-tier bioterrorism agent due to its high lethality and spore stability. The current FDA-approved anthrax vaccine and other vaccine candidates in development lack ease of preparation, have short shelf lives and adverse effects. B. Kim Lee Sim of Protein Potential LLC and her collaborators combined key B. anthracis genetic material into an existing typhoid vaccine. The vaccine vector possesses high stability, a strong safety record, and offers long-term protection after oral administration, which Sim’s group hopes to preserve in their candidate anthrax vaccine. The team showed that their hybrid vaccine conferred excellent protection in rabbits and a short vaccination regimen, and suggest further studies into its suitability for human vaccine studies.
format article
author B. Kim Lee Sim
Minglin Li
Manuel Osorio
Yun Wu
Tint T. Wai
Johnny W. Peterson
Eric R. James
Sumana Chakravarty
Lixin Gao
Rui Xu
Natasha KC
Richard E. Stafford
William S. Lawrence
Linsey A. Yeager
Jennifer E. Peel
Satheesh K. Sivasubramani
Ashok K. Chopra
Svetlana Filippova
Stephen L. Hoffman
author_facet B. Kim Lee Sim
Minglin Li
Manuel Osorio
Yun Wu
Tint T. Wai
Johnny W. Peterson
Eric R. James
Sumana Chakravarty
Lixin Gao
Rui Xu
Natasha KC
Richard E. Stafford
William S. Lawrence
Linsey A. Yeager
Jennifer E. Peel
Satheesh K. Sivasubramani
Ashok K. Chopra
Svetlana Filippova
Stephen L. Hoffman
author_sort B. Kim Lee Sim
title Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis
title_short Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis
title_full Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis
title_fullStr Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis
title_full_unstemmed Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis
title_sort protection against inhalation anthrax by immunization with salmonella enterica serovar typhi ty21a stably producing protective antigen of bacillus anthracis
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/e6ed55cb74e9406db34a5f3fb0bf3838
work_keys_str_mv AT bkimleesim protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT minglinli protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT manuelosorio protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT yunwu protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT tinttwai protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT johnnywpeterson protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT ericrjames protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT sumanachakravarty protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT lixingao protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT ruixu protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT natashakc protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT richardestafford protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT williamslawrence protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT linseyayeager protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT jenniferepeel protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT satheeshksivasubramani protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT ashokkchopra protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT svetlanafilippova protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
AT stephenlhoffman protectionagainstinhalationanthraxbyimmunizationwithsalmonellaentericaserovartyphity21astablyproducingprotectiveantigenofbacillusanthracis
_version_ 1718384205431308288